comparemela.com

Latest Breaking News On - ராஜீப் தாஸ்குப்தா - Page 23 : comparemela.com

Efficacy data for India s own COVID-19 vaccine could boost public acceptance | WSAU News/Talk 550 AM · 99 9 FM

Efficacy data for India s own coronavirus vaccine could boost its public acceptance

Efficacy data for India s own coronavirus vaccine could boost its public acceptance SECTIONS Last Updated: Mar 04, 2021, 03:18 PM IST Share Synopsis Any boost to the vaccine s acceptance in India, which on Thursday reported a new COVID-19 cases at their highest in five weeks, could also brighten its export prospects. Bharat Biotech said 40 countries were interested in COVAXIN. Bharat Biotech Covaxin Efficacy Data: How effective is the vaccine? Indian doctors and politicians on Thursday welcomed efficacy data for a state-backed coronavirus vaccine that was given emergency approval in January without the completion of a late-stage trial, making people reluctant to receive the shot.

COVID-19 vaccination: Covaxin s efficacy data likely to bolster public acceptance

Government data shows that only 10% of about 12.6 million people immunised in India have taken the COVAXIN shot, which was found to be 81% effective in an interim analysis of the late-stage trial, its developer Bharat Biotech said

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.